Skip to main content
Top
Published in: BMC Public Health 1/2012

Open Access 01-12-2012 | Research article

Impact of genital warts on health related quality of life in men and women in mainland China: a multicenter hospital-based cross-sectional study

Authors: Ju-Fang Shi, Dian-Ju Kang, Shu-Zhen Qi, Hai-Yan Wu, Yan-Chun Liu, Li-Jun Sun, Li Li, Ying Yang, Qing Li, Xiang-Xian Feng, Li-Qin Zhang, Jie Li, Xiao-Li Li, Yun Yang, Mayinuer Niyazi, Ai-Di Xu, Jia-Hua Liu, Qing Xiao, Lian-Kun Li, Xin-Zheng Wang, You-Lin Qiao

Published in: BMC Public Health | Issue 1/2012

Login to get access

Abstract

Background

Information on the health-related quality of life (HRQoL) of patients with genital warts (GW) in populations in mainland China is still limited. The aim of the study was to use a generic instrument to measure the impact of genital warts on HRQoL in men and women in this setting.

Methods

A multi-centre hospital-based cross-sectional study across 18 centers in China was conducted to interview patients using the European quality of life-5 dimension (EQ-5D) instrument; respondents' demographic and clinical data were also collected.

Results

A total of 1,358 GW patients (612 men, 746 women) were included in the analysis, with a mean age of 32.0 ± 10.6 years. 56.4% of the patients reported some problems in the dimension of Anxiety/Depression (highest), followed by Pain/Discomfort (24.7%) and Mobility (3.5%). The overall visual analogue scale (VAS) score of the study population was found to be 65.2 ± 22.0, and the EQ-5D index score was found to be 0.843 ± 0.129 using Japanese preference weights (the Chinese preference was unavailable yet). Patients with lower VAS means and EQ-5D index scores were more often female, living in urban area, and suffering multiple GW (all p values < 0.05), but the values did not differ notably by age (p values > 0.05).

Conclusions

The HRQoL of patients with GW was substantially lower, compared to a national representative general population in China (VAS = ~80); the findings of different subgroups are informative for future GW prevention and control efforts.
Appendix
Available only for authorised users
Literature
1.
go back to reference Parkin DM, Louie KS, Clifford G: Burden and trends of type-specific human papillomavirus infections and related diseases in the Asia Pacific region. Vaccine. 2008, 26 (Suppl 12): M1-16.CrossRefPubMed Parkin DM, Louie KS, Clifford G: Burden and trends of type-specific human papillomavirus infections and related diseases in the Asia Pacific region. Vaccine. 2008, 26 (Suppl 12): M1-16.CrossRefPubMed
2.
go back to reference Pirotta M, Stein AN, Conway EL, Harrison C, Britt H, Garland S: Genital warts incidence and healthcare resource utilisation in Australia. Sex Transm Infect. 2010, 86: 181-186. 10.1136/sti.2009.040188.CrossRefPubMed Pirotta M, Stein AN, Conway EL, Harrison C, Britt H, Garland S: Genital warts incidence and healthcare resource utilisation in Australia. Sex Transm Infect. 2010, 86: 181-186. 10.1136/sti.2009.040188.CrossRefPubMed
3.
go back to reference Koshiol JE, Laurent SA, Pimenta JM: Rate and predictors of new genital warts claims and genital warts-related healthcare utilization among privately insured patients in the United States. Sex Transm Dis. 2004, 31: 748-752. 10.1097/01.olq.0000145851.76025.ad.CrossRefPubMed Koshiol JE, Laurent SA, Pimenta JM: Rate and predictors of new genital warts claims and genital warts-related healthcare utilization among privately insured patients in the United States. Sex Transm Dis. 2004, 31: 748-752. 10.1097/01.olq.0000145851.76025.ad.CrossRefPubMed
4.
go back to reference O'Mahony C: Genital warts: current and future management options. Am J Clin Dermatol. 2005, 6: 239-243. 10.2165/00128071-200506040-00004.CrossRefPubMed O'Mahony C: Genital warts: current and future management options. Am J Clin Dermatol. 2005, 6: 239-243. 10.2165/00128071-200506040-00004.CrossRefPubMed
5.
go back to reference Wang SM, Shi JF, Kang DJ, Song P, Qiao YL: Chinese HPV Study Group: Impact of Human Papillomavirus Related Lesions on Quality of Life: A Multicenter Hospital-Based Study of Women in Mainland China. Int J Gynecol Cancer. 2011, 21: 182-188. 10.1097/IGC.0b013e3181ffbed8.CrossRefPubMed Wang SM, Shi JF, Kang DJ, Song P, Qiao YL: Chinese HPV Study Group: Impact of Human Papillomavirus Related Lesions on Quality of Life: A Multicenter Hospital-Based Study of Women in Mainland China. Int J Gynecol Cancer. 2011, 21: 182-188. 10.1097/IGC.0b013e3181ffbed8.CrossRefPubMed
6.
go back to reference Pirotta M, Ung L, Stein A, Conway EL, Mast TC, Fairley CK, et al: The psychosocial burden of human papillomavirus related disease and screening interventions. Sex Transm Infect. 2009, 85: 508-513. 10.1136/sti.2009.037028.CrossRefPubMed Pirotta M, Ung L, Stein A, Conway EL, Mast TC, Fairley CK, et al: The psychosocial burden of human papillomavirus related disease and screening interventions. Sex Transm Infect. 2009, 85: 508-513. 10.1136/sti.2009.037028.CrossRefPubMed
7.
go back to reference Wang D, Shi JF, Li L, Yan SW, Sun LJ, Li CQ, et al: Measuring direct costs of treating genital warts in China [abstract]. The 4th Asian Pacific Organization for Cancer Prevention General Assembly Conference, Beijing. 2008 Wang D, Shi JF, Li L, Yan SW, Sun LJ, Li CQ, et al: Measuring direct costs of treating genital warts in China [abstract]. The 4th Asian Pacific Organization for Cancer Prevention General Assembly Conference, Beijing. 2008
8.
go back to reference Wang H, Qiao YL: Human papillomavirus type-distribution in condylomata acuminata of mainland China: a meta-analysis. Int J STD AIDS. 2008, 19: 680-684. 10.1258/ijsa.2008.008040.CrossRefPubMed Wang H, Qiao YL: Human papillomavirus type-distribution in condylomata acuminata of mainland China: a meta-analysis. Int J STD AIDS. 2008, 19: 680-684. 10.1258/ijsa.2008.008040.CrossRefPubMed
9.
go back to reference Woodhall S, Ramsey T, Cai C, Crouch S, Jit M, Birks Y, et al: Estimation of the impact of genital warts on health-related quality of life. Sex Transm Infect. 2008, 84: 161-166. 10.1136/sti.2007.029512.CrossRefPubMed Woodhall S, Ramsey T, Cai C, Crouch S, Jit M, Birks Y, et al: Estimation of the impact of genital warts on health-related quality of life. Sex Transm Infect. 2008, 84: 161-166. 10.1136/sti.2007.029512.CrossRefPubMed
10.
go back to reference Myers E, Green S, Lipkus I: Patient preferences for health states related to HPV infection: visual analogue scales vs. time trade-off elicitation [abstract]. The 21st International Papillomavirus Conference, Mexico City, Mexico. 2004 Myers E, Green S, Lipkus I: Patient preferences for health states related to HPV infection: visual analogue scales vs. time trade-off elicitation [abstract]. The 21st International Papillomavirus Conference, Mexico City, Mexico. 2004
11.
go back to reference Marra C, Ogilvie G, Gastonguay L, Colley L, Taylor D, Marra F: Patients with genital warts have a decreased quality of life. Sex Transm Dis. 2009, 36: 258-260. 10.1097/OLQ.0b013e318191a55e.CrossRefPubMed Marra C, Ogilvie G, Gastonguay L, Colley L, Taylor D, Marra F: Patients with genital warts have a decreased quality of life. Sex Transm Dis. 2009, 36: 258-260. 10.1097/OLQ.0b013e318191a55e.CrossRefPubMed
13.
go back to reference Rabin R, de CF: EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001, 33: 337-343. 10.3109/07853890109002087.CrossRefPubMed Rabin R, de CF: EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001, 33: 337-343. 10.3109/07853890109002087.CrossRefPubMed
14.
go back to reference Coons SJ, Rao S, Keininger DL, Hays RD: A comparative review of generic quality-of-life instruments. Pharmacoeconomics. 2000, 17: 13-35. 10.2165/00019053-200017010-00002.CrossRefPubMed Coons SJ, Rao S, Keininger DL, Hays RD: A comparative review of generic quality-of-life instruments. Pharmacoeconomics. 2000, 17: 13-35. 10.2165/00019053-200017010-00002.CrossRefPubMed
15.
go back to reference Sun S, Chen J, Johannesson M, Kind P, Xu L, Zhang Y, et al: Population health status in China: EQ-5D results, by age, sex and socio-economic status, from the National Health Services Survey 2008. Qual Life Res. 2010, 20: 309-320.CrossRefPubMedPubMedCentral Sun S, Chen J, Johannesson M, Kind P, Xu L, Zhang Y, et al: Population health status in China: EQ-5D results, by age, sex and socio-economic status, from the National Health Services Survey 2008. Qual Life Res. 2010, 20: 309-320.CrossRefPubMedPubMedCentral
16.
go back to reference Li MH, Luo N: An introduction to application of EQ-5D Chinese version. China Journal of Pharmaceutical Ecomomics. 2009, 1: 49-57. Li MH, Luo N: An introduction to application of EQ-5D Chinese version. China Journal of Pharmaceutical Ecomomics. 2009, 1: 49-57.
17.
go back to reference Wang H, Kindig DA, Mullahy J: Variation in Chinese population health related quality of life: results from a EuroQol study in Beijing, China. Qual Life Res. 2005, 14: 119-132. 10.1007/s11136-004-0612-6.CrossRefPubMed Wang H, Kindig DA, Mullahy J: Variation in Chinese population health related quality of life: results from a EuroQol study in Beijing, China. Qual Life Res. 2005, 14: 119-132. 10.1007/s11136-004-0612-6.CrossRefPubMed
18.
go back to reference Zhang LC, Wang H, Wang LS, Xiao QL: Health Related Quality of Life in West Rural Population. Chinese Health Economics. 2005, 24: 8-11. Zhang LC, Wang H, Wang LS, Xiao QL: Health Related Quality of Life in West Rural Population. Chinese Health Economics. 2005, 24: 8-11.
19.
go back to reference Luo N, Chew LH, Fong KY, Koh DR, Ng SC, Yoon KH, et al: Do English and Chinese EQ-5D versions demonstrate measurement equivalence?. An exploratory study Health Qual Life Outcomes. 2003, 1: 7-10.1186/1477-7525-1-7.CrossRefPubMed Luo N, Chew LH, Fong KY, Koh DR, Ng SC, Yoon KH, et al: Do English and Chinese EQ-5D versions demonstrate measurement equivalence?. An exploratory study Health Qual Life Outcomes. 2003, 1: 7-10.1186/1477-7525-1-7.CrossRefPubMed
20.
go back to reference Tsuchiya A, Ikeda S, Ikegami N, Nishimura S, Sakai I, Fukuda T, et al: Estimating an EQ-5D population value set: the case of Japan. Health Econ. 2002, 11: 341-353. 10.1002/hec.673.CrossRefPubMed Tsuchiya A, Ikeda S, Ikegami N, Nishimura S, Sakai I, Fukuda T, et al: Estimating an EQ-5D population value set: the case of Japan. Health Econ. 2002, 11: 341-353. 10.1002/hec.673.CrossRefPubMed
21.
go back to reference Dolan P: Modeling wfiuations for EuroQol health states. Med Care. 1997, 35: 1095-1108. 10.1097/00005650-199711000-00002.CrossRefPubMed Dolan P: Modeling wfiuations for EuroQol health states. Med Care. 1997, 35: 1095-1108. 10.1097/00005650-199711000-00002.CrossRefPubMed
22.
go back to reference Shaw JW, Johnson JA, Coons SJ: US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care. 2005, 43: 203-220. 10.1097/00005650-200503000-00003.CrossRefPubMed Shaw JW, Johnson JA, Coons SJ: US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care. 2005, 43: 203-220. 10.1097/00005650-200503000-00003.CrossRefPubMed
23.
go back to reference Prieto L, Sacristan JA: What is the value of social values? The uselessness of assessing health-related quality of life through preference measures. BMC Med Res Methodol. 2004, 4: 10-10.1186/1471-2288-4-10.CrossRefPubMedPubMedCentral Prieto L, Sacristan JA: What is the value of social values? The uselessness of assessing health-related quality of life through preference measures. BMC Med Res Methodol. 2004, 4: 10-10.1186/1471-2288-4-10.CrossRefPubMedPubMedCentral
24.
go back to reference Brisson M, Van d V, De WP, Boily MC: The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada. Vaccine. 2007, 25: 5399-5408. 10.1016/j.vaccine.2007.04.086.CrossRefPubMed Brisson M, Van d V, De WP, Boily MC: The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada. Vaccine. 2007, 25: 5399-5408. 10.1016/j.vaccine.2007.04.086.CrossRefPubMed
25.
26.
go back to reference Kulasingam SL, Benard S, Barnabas RV, Largeron N, Myers ER: Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: A cost-effectiveness analysis. Cost Eff Resour Alloc. 2008, 6: 4-10.1186/1478-7547-6-4.CrossRefPubMedPubMedCentral Kulasingam SL, Benard S, Barnabas RV, Largeron N, Myers ER: Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: A cost-effectiveness analysis. Cost Eff Resour Alloc. 2008, 6: 4-10.1186/1478-7547-6-4.CrossRefPubMedPubMedCentral
27.
go back to reference Elbasha EH, Dasbach EJ, Insinga RP: Model for assessing human papillomavirus vaccination strategies. Emerg Infect Dis. 2007, 13: 28-41. 10.3201/eid1301.060438.CrossRefPubMedPubMedCentral Elbasha EH, Dasbach EJ, Insinga RP: Model for assessing human papillomavirus vaccination strategies. Emerg Infect Dis. 2007, 13: 28-41. 10.3201/eid1301.060438.CrossRefPubMedPubMedCentral
28.
go back to reference Sinnott PL, Joyce VR, Barnett PG: Preference Measurement in Economic Analysis. 2007, VA Palo Alto, Health Economics Resource Center: Guidebook. Menlo Park CA Sinnott PL, Joyce VR, Barnett PG: Preference Measurement in Economic Analysis. 2007, VA Palo Alto, Health Economics Resource Center: Guidebook. Menlo Park CA
Metadata
Title
Impact of genital warts on health related quality of life in men and women in mainland China: a multicenter hospital-based cross-sectional study
Authors
Ju-Fang Shi
Dian-Ju Kang
Shu-Zhen Qi
Hai-Yan Wu
Yan-Chun Liu
Li-Jun Sun
Li Li
Ying Yang
Qing Li
Xiang-Xian Feng
Li-Qin Zhang
Jie Li
Xiao-Li Li
Yun Yang
Mayinuer Niyazi
Ai-Di Xu
Jia-Hua Liu
Qing Xiao
Lian-Kun Li
Xin-Zheng Wang
You-Lin Qiao
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2012
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-12-153

Other articles of this Issue 1/2012

BMC Public Health 1/2012 Go to the issue